RiaSTAP

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 63833-891
  • Package NDC 63833-891-51
  • Application number BLA125317
  • SPL ID 703efe5b-eb9f-4690-abb8-e446feaa702f
  • SPL set ID 903dc8d0-39da-462c-9dac-004e0c7a26cc
  • UNII N94833051K
  • RxCUI 831506
  • RxCUI 831509

What the source publishes

Labeler
CSL Behring GmbH
Active ingredients
FIBRINOGEN HUMAN
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
PLASMA DERIVATIVE

Names this record is found by

Complete source data
us:fda:ndc:63833-891_703efe5b-eb9f-4690-abb8-e446feaa702f
{
  "name": "RiaSTAP",
  "splId": "703efe5b-eb9f-4690-abb8-e446feaa702f",
  "labels": [
    {
      "setId": "903dc8d0-39da-462c-9dac-004e0c7a26cc",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=903dc8d0-39da-462c-9dac-004e0c7a26cc",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=903dc8d0-39da-462c-9dac-004e0c7a26cc"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "CSL Behring GmbH",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51)  / 50 mL in 1 VIAL, SINGLE-USE (63833-891-90)",
      "package_ndc": "63833-891-51",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20090116"
    }
  ],
  "productId": "63833-891_703efe5b-eb9f-4690-abb8-e446feaa702f",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "63833-891",
  "deaSchedule": null,
  "genericName": "FIBRINOGEN HUMAN",
  "productType": "PLASMA DERIVATIVE",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "FIBRINOGEN HUMAN",
      "strength": "1300 mg/50mL"
    }
  ],
  "applicationNumber": "BLA125317",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20090116",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000184169",
      "N0000175979",
      "M0002684"
    ],
    "unii": [
      "N94833051K"
    ],
    "rxcui": [
      "831506",
      "831509"
    ],
    "spl_set_id": [
      "903dc8d0-39da-462c-9dac-004e0c7a26cc"
    ],
    "pharm_class_cs": [
      "Blood Coagulation Factors [CS]"
    ],
    "pharm_class_pe": [
      "Increased Coagulation Activity [PE]"
    ],
    "pharm_class_epc": [
      "Human Blood Coagulation Factor [EPC]"
    ],
    "manufacturer_name": [
      "CSL Behring GmbH"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:63833-891_703efe5b-eb9f-4690-abb8-e446feaa702f"